课题基金 / 基金详情

项目摘要

项目成果

Douglas Paul Millay的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Sarcopenia is a devastating skeletal muscle condition that occurs in advanced age and due to various chronic conditions. Despite the widespread prevalence of sarcopenia there are no treatment options and the mechanisms underlying this process are not completely understood. Hallmark characteristics of skeletal muscle aging are a reduction in myofiber size and number, dysregulated muscle function, and an increased incidence of fibrosis. An additional process altered during aging is the activity of muscle stem cells (MuSCs), which typically are quiescent but in a young environment function to fully repair damaged muscle and allow muscle to adapt to external stimuli. Although MuSCs are clearly required for development and regeneration, we still do not understand their exact role during muscle homeostasis and aging. To this end, we have generated a unique mouse model that ablates MuSC fusion activity but maintains their presence within the tissue. Our recent studies showed that MuSC fusion is required for muscle growth in a young environment, and that without MuSC fusion, pronounced development of fibrosis ensues. Moreover, our preliminary data indicate that MuSC fusion is dysregulated in aged skeletal muscle. Thus, we hypothesize that fusion of MuSCs with myofibers is necessary to maintain myofiber integrity, and dysregulation of this process leads to pathological extracellular matrix (ECM) remodeling during aging. To definitively answer these questions, we have generated numerous novel genetic reagents to manipulate both MuSC fusion and fibrosis in vivo. Based on these preliminary data and unique mouse models we propose to comprehensively determine the role for MuSCs and evaluate the consequences of fibrosis development during skeletal muscle aging. Specifically, we propose to: 1) elucidate the requirement of MuSC fusion for muscle adaptation during aging 2) molecularly dissect the mechanisms of fusion in aged skeletal muscle and 3) define the relationship between fibrosis and MuSC fusion during the development of sarcopenia. Successful completion of these studies will provide unique insight into the general mechanisms of MuSC-dependent muscle aging and provide new knowledge that will identify new therapeutic strategies to combat sarcopenia.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41467-020-20804-x
发表时间: 2021-01-21
期刊: Nature communications
影响因子: 16.6
作者: [Golani G, Leikina E, Melikov K, Whitlock JM, Gamage DG, Luoma-Overstreet G, Millay DP, Kozlov MM, Chernomordik LV]
通讯作者: Chernomordik LV
DOI: 10.1016/j.tcb.2019.09.002
发表时间: 2019-12
期刊: Trends in cell biology
影响因子: 19
作者: [Petrany MJ, Millay DP]
通讯作者: Millay DP
Skeletal muscle fibers count on nuclear numbers for growth.
骨骼肌纤维的生长依赖于核数量。
DOI: 10.1016/j.semcdb.2021.04.015
发表时间: 2021-11
期刊: SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
影响因子: 7.3
作者: [Prasad, Vikram, Millay, Douglas P.]
通讯作者: Millay, Douglas P.
Fibroblast fusion to the muscle fiber regulates myotendinous junction formation.
成纤维细胞融合到肌肉纤维可调节肌肌的形成。
DOI: 10.1038/s41467-021-24159-9
发表时间: 2021-06-22
期刊: Nature communications
影响因子: 16.6
作者: [Yaseen W, Kraft-Sheleg O, Zaffryar-Eilot S, Melamed S, Sun C, Millay DP, Hasson P]
通讯作者: Hasson P
7
    Myonuclear dynamics during skeletal muscle aging
    • 批准号:
      10714194
    • 项目类别:
    • 资助金额:
      $42.34万
    • 财政年份:
      2023
    • 负责人:
      Douglas Paul Millay
    • 依托单位:
    Improving delivery of therapeutic material to skeletal muscle
    • 批准号:
      10022097
    • 项目类别:
    • 资助金额:
      $39.75万
    • 财政年份:
      2019
    • 负责人:
      Douglas Paul Millay
    • 依托单位:
    Improving delivery of therapeutic material to skeletal muscle
    • 批准号:
      9906360
    • 项目类别:
    • 资助金额:
      $39.75万
    • 财政年份:
      2019
    • 负责人:
      Douglas Paul Millay
    • 依托单位:
    Improving delivery of therapeutic material to skeletal muscle
    • 批准号:
      10617940
    • 项目类别:
    • 资助金额:
      $39.75万
    • 财政年份:
      2019
    • 负责人:
      Douglas Paul Millay
    • 依托单位:
    海外基金